Covid-19: financing Tyvek suits
Description
During the Covid-19 pandemic, the Hôpitaux Robert Schuman Foundation found a quick and practical solution to cover its needs for protective gowns and overalls. Seamstresses from Luxembourg made the protective clothing in March 2020, with a daily quota of around 250 units. Production was overseen by 10 employees at Ateliers Eva Ferranti on the company's premises in Bascharage. The seamstresses worked in full compliance with the safety measures prescribed by the Health Department. It soon became apparent that there was a shortage of Tyvek masks and protective clothing. Tyvek is a non-woven polyethylene fabric from the American group DuPont, which is only produced at two sites in the world, in the United States and here in Contern. After manufacturing the fabric, Dupont has protective clothing sewn on third-party sites. "The problem was that there weren't enough tyvek suits for the whole country," explains Dr Wilmes. This situation was compounded by contradictory statements and information. At the same time, the number of reports of theft and the pressure exerted by national hospitals increased. "We've had a lot of requests from nurses and doctors, especially from Covid-19 departments. So we looked for other solutions”. Jean-Louis Schiltz, Chairman of the "Hôpitaux Robert Schuman Foundation", the body responsible for the Hôpitaux Robert Schuman, suggested manufacturing them in Luxembourg. He also had national needs in mind.
Added value
By producing the protective gowns and overalls locally, the hospitals were able to access the necessary equipment more quickly than if they had been waiting for deliveries from other countries. Local production reduces waiting times and ensures a faster supply of essential protective equipment. Adaptability: By producing gowns and protective suits locally, hospitals can quickly adjust their production to meet changing needs and demands. This allows greater flexibility to respond to fluctuations in demand and to adapt to changes in the operational environment, such as the increase in cases of COVID-19 or other medical emergencies.
Status
Production cycle from 30 March 2020 to 31 May 2020.